Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation01:24

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

566
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
566
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

96
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
96
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

64
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
64
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

103
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
103
Variability: Analysis01:11

Variability: Analysis

158
Measures of variability are statistical metrics that reveal the dispersion pattern within a dataset. They are pivotal in biostatistics, providing insights into the heterogeneity within health and biological data. Variability signifies the degree to which data points diverge from one another, helping researchers understand the potential range of values and associated uncertainty within the data.
The range is a simple measure of variability, indicating the difference between the highest and...
158
Variation01:19

Variation

6.8K
An important characteristic of any set of data is the variation in the data. In some data sets, the data values are concentrated closely near the mean; in other data sets, the data values are more widely spread out from the mean. The most common measure of variation, or spread, is the standard deviation, which is the square root of variance.
When independent and dependent variables are plotted on a scatter plot, the slope of a line is a value that describes the rate of change between the two...
6.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Advancing quantitative clinical pharmacology competencies in Francophone Africa through an on-line learning framework.

Journal of pharmacokinetics and pharmacodynamics·2026
Same author

Blood Never Lies: The PopPK-Based Lie Detector.

Clinical pharmacokinetics·2026
Same author

External Evaluation of Population Pharmacokinetic Models of Cabotegravir, During Its Oral and Intramuscular Administration in HIV-Infected Patients.

CPT: pharmacometrics & systems pharmacology·2026
Same author

Novel Drug-Disease Modeling Framework for Oncology Benefit-Risk Evaluation: Application to Tusamitamab Ravtansine.

CPT: pharmacometrics & systems pharmacology·2026
Same author

Population pharmacokinetic modelling of amoxicillin in human breast milk-A contribution from the ConcePTION project.

British journal of clinical pharmacology·2026
Same author

Could a macular telangiectasia type 2-like phenotype characterize retinal JC virus infection?

AIDS (London, England)·2026

Related Experiment Video

Updated: Jul 16, 2025

A Psychophysics Paradigm for the Collection and Analysis of Similarity Judgments
08:12

A Psychophysics Paradigm for the Collection and Analysis of Similarity Judgments

Published on: March 1, 2022

2.6K

Multivariate Exact Discrepancy: A New Tool for PK/PD Model Evaluation.

Sarah Baklouti1,2, Emmanuelle Comets3,4, Peggy Gandia1,2

  • 1Laboratoire de Pharmacocinétique et Toxicologie, Institut Fédératif de Biologie, CHU de Toulouse, Toulouse, France.

Clinical Pharmacokinetics
|September 17, 2023
PubMed
Summary

This study introduces a new method for evaluating pharmacokinetic models, addressing limitations in current approaches for analyzing dependent concentration data within individuals. The method assigns a probability score to assess model fit for each patient, aiding in model selection for therapeutic drug monitoring.

More Related Videos

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
04:35

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Published on: July 3, 2020

3.4K
Basics of Multivariate Analysis in Neuroimaging Data
06:35

Basics of Multivariate Analysis in Neuroimaging Data

Published on: July 24, 2010

16.9K

Related Experiment Videos

Last Updated: Jul 16, 2025

A Psychophysics Paradigm for the Collection and Analysis of Similarity Judgments
08:12

A Psychophysics Paradigm for the Collection and Analysis of Similarity Judgments

Published on: March 1, 2022

2.6K
Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach
04:35

Development of an Individual-Tree Basal Area Increment Model using a Linear Mixed-Effects Approach

Published on: July 3, 2020

3.4K
Basics of Multivariate Analysis in Neuroimaging Data
06:35

Basics of Multivariate Analysis in Neuroimaging Data

Published on: July 24, 2010

16.9K

Area of Science:

  • Pharmacometrics
  • Pharmacokinetic modeling
  • Statistical analysis

Background:

  • Pharmacokinetic (PK) models are crucial for drug development and therapeutic drug monitoring.
  • Current evaluation metrics, such as Visual Predictive Check (VPC) and Normalised Prediction Distribution Error (NPDE), have limitations, particularly with dependent concentration data from the same patient.
  • There is a need for improved methods to accurately assess PK model performance in complex scenarios.

Purpose of the Study:

  • To propose a novel evaluation method for pharmacokinetic models that explicitly accounts for the dependency between concentration measurements within an individual.
  • To provide a robust approach for assessing model fit and identifying potential issues in PK model development.
  • To facilitate the selection of appropriate models for therapeutic drug monitoring.

Main Methods:

  • The proposed method analyzes the distribution of simulated concentration vectors to generate an individual probability score.
  • This score reflects the likelihood that an individual's observed concentrations originate from the studied PK model.
  • Aggregate analysis of these individual probabilities allows for a comprehensive evaluation of the overall model performance.

Main Results:

  • The method's effectiveness was demonstrated through two illustrative examples.
  • The approach successfully identified structural model misspecifications.
  • Outlier kinetics within datasets were effectively detected, highlighting the method's sensitivity.

Conclusions:

  • A straightforward and effective method for evaluating PK models during development has been presented.
  • The method shows promise for selecting optimal models for therapeutic drug monitoring.
  • Further validation on a larger scale is recommended to confirm the method's broad applicability and robustness.